Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -5221.43% is 503% below its 5-year average of -865.26%, near the low end of its 5-year range (-5221.43%–-175.55%).
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2023 (2023-04-30): -1213.33%.
EBITDA MARGIN
-5221.43%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
-822.96%
EBITDA MARGIN AVG 5Y
-865.26%
EBITDA MARGIN AVG 10Y
-585.75%
EBITDA MARGIN AVG 15Y
-646.18%
EBITDA MARGIN AVG 20Y
-906.57%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-534.47%
CURRENT VS 5Y AVG
-503.45%
CURRENT VS 10Y AVG
-791.41%
CURRENT VS 15Y AVG
-708.05%
CURRENT VS 20Y AVG
-475.96%
Anixa Biosciences, Inc.
Market Cap
$100.37M
EBITDA Margin
-5221.43%
TTM Avg
N/A
3Y Avg
-822.96%
5Y Avg
-865.26%
Market Cap
$104.07M
EBITDA Margin
6.31%
TTM Avg
-127.53%
3Y Avg
-89.97%
5Y Avg
-50.55%
Market Cap
$106.23M
EBITDA Margin
5.60%
TTM Avg
2.28%
3Y Avg
0.00%
5Y Avg
-2.15%
Market Cap
$108.39M
EBITDA Margin
-6164.17%
TTM Avg
-4620.17%
3Y Avg
-2654.54%
5Y Avg
-2163.85%
Market Cap
$91.68M
EBITDA Margin
-19.79%
TTM Avg
-29.84%
3Y Avg
-150.95%
5Y Avg
-150.95%
Market Cap
$91.33M
EBITDA Margin
-35.83%
TTM Avg
-39.56%
3Y Avg
-111.97%
5Y Avg
-250.85%
Market Cap
$109.49M
EBITDA Margin
-10.96%
TTM Avg
-24.45%
3Y Avg
-32.87%
5Y Avg
-38.11%
Market Cap
$109.93M
EBITDA Margin
-624817.90%
TTM Avg
-624817.90%
3Y Avg
-624817.90%
5Y Avg
-624817.90%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anixa Biosciences, Inc. (ANIX) | $100.37M | -5221.43% | N/A | -822.96% | -865.26% |
| Definitive Healthcare Corp. (DH)vs › | $104.07M | 6.31% | -127.53% | -89.97% | -50.55% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.23M | 5.60% | 2.28% | 0.00% | -2.15% |
| Biomea Fusion, Inc. (BMEA)vs › | $93.99M | N/A | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.39M | -6164.17% | -4620.17% | -2654.54% | -2163.85% |
| Equillium, Inc. (EQ)vs › | $91.68M | -19.79% | -29.84% | -150.95% | -150.95% |
| electroCore, Inc. (ECOR)vs › | $91.33M | -35.83% | -39.56% | -111.97% | -250.85% |
| Apyx Medical Corporation (APYX)vs › | $109.49M | -10.96% | -24.45% | -32.87% | -38.11% |
| Immunic, Inc. (IMUX)vs › | $109.93M | -624817.90% | -624817.90% | -624817.90% | -624817.90% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $111.17M | 28.85% | 28.85% | 28.85% | 28.85% |
Gross Margin
0.0%
EBITDA Margin
-5221.4%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2023-04-30 | -1213.33% |
| 2021-01-31 | -432.58% |
| 2019-04-30 | -982.25% |
| 2018-07-31 | -1522.60% |
| 2018-04-30 | -175.55% |
| 2017-07-31 | -452.08% |
| 2016-10-31 | -399.32% |
| 2016-07-31 | -893.56% |
| 2015-07-31 | -1483.58% |
| 2015-04-30 | -8207.66% |
| 2015-01-31 | 43.11% |
| 2014-10-31 | -107.87% |
| 2014-07-31 | -6.59% |
| 2014-04-30 | -115.29% |
| 2013-10-31 | -459.04% |
| 2012-10-31 | -492615.14% |
| 2012-07-31 | -257.20% |
| 2012-04-30 | -353.27% |
| 2012-01-31 | -197.06% |
| 2011-10-31 | -223.84% |
| 2011-07-31 | -267.71% |
| 2011-04-30 | -1479.03% |
| 2011-01-31 | -8988.14% |
| 2010-10-31 | -361.42% |
| 2010-07-31 | -2185.37% |
| 2010-04-30 | -414.94% |
| 2010-01-31 | -3880.83% |
| 2009-10-31 | -2825.85% |
| 2009-07-31 | -396.23% |
| 2009-04-30 | -523.49% |
| 2009-01-31 | -368.65% |
| 2008-10-31 | -61.49% |
| 2008-07-31 | -83.73% |
| 2008-04-30 | -1185.60% |
| 2008-01-31 | -5151.23% |
| 2007-10-31 | -826.64% |
| 2007-07-31 | -930.32% |
| 2007-04-30 | -1490.98% |
| 2007-01-31 | -1361.37% |
| 2006-10-31 | -1627.28% |
| 2006-07-31 | -1643.92% |
| 2006-04-30 | -3376.43% |
| 2006-01-31 | -635.57% |
| 2005-10-31 | -2369.85% |
| 2005-07-31 | -847.33% |
| 2005-04-30 | -2528.18% |
| 2005-01-31 | -472.67% |
| 2004-10-31 | -600.15% |
| 2004-07-31 | -476.89% |
| 2004-04-30 | -679.13% |
| 2004-01-31 | -2061.91% |
| 2003-10-31 | -1427.36% |
| 2003-07-31 | -773.72% |
| 2003-04-30 | -4424.95% |
| 2003-01-31 | -871.64% |
| 2002-10-31 | -10401.39% |